Key facts
- This page summarizes Christine Fox Harbison's Form 4 filing for MERCURY SYSTEMS INC (MRCY).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 21 Aug 2023, 19:29.
Christine Fox Harbison - 17 Aug 2023 Form 4 Insider Report for MERCURY SYSTEMS INC (MRCY)
- Reporting relationship
- EVP and Chief Growth Officer
- Issuer ticker
- MRCY
- Reported as of
- 17 Aug 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 21 Aug 2023, 19:29:47 UTC
- Prior SEC filing
- 17 Mar 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michelle McCarthy, Attorney-in-Fact for Christine Harbison
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Christine Fox Harbison filed Form 4 for MERCURY SYSTEMS INC (MRCY) on 21 Aug 2023.
Change
- Previous filing in this sequence was filed on 17 Mar 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MRCY
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +9,844
- Change %
- +32%
- Price
- $0.000000
- Shares after
- 40,188
- Date
- 17 Aug 2023
- Ownership
- Direct
- Footnotes
- F1
MRCY
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +12,032
- Change %
- +30%
- Price
- $0.000000
- Shares after
- 52,220
- Date
- 17 Aug 2023
- Ownership
- Direct
- Footnotes
- F2
MRCY
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 248
- Date
- 17 Aug 2023
- Ownership
- 401K Plan
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These shares of restricted stock vest in equal annual increments over the three-year period following the grant date.
Footnote F2
These shares of performance-based restricted stock vest between 0% and 225% of the amount listed in the table depending on the achievement of performance objectives for the three fiscal years ending July 3, 2026.